Company: Atara Bio
Job title: Chief Commercial Officer
With more than 20 years of biopharmaceutical experience ranging from research to bringing products to market, Dr. Kristin Yarema was named Atara’s Chief Commercial Officer in February of 2020.
Kristin came to Atara after serving as Amgen’s Vice President & Therapeutic Area Head, Global Product Strategy & Commercial Innovation, Hematology and Oncology. In her seven years at Amgen, Dr. Yarema strategically managed the company’s pipeline in small molecule and immuno-oncology for hematological malignancies, such as multiple myeloma, leukemias, and lymphomas, and was recognized as having the top therapeutic area in 2018 while leading the Cardiovascular, Metabolism and Neuroscience business unit.
Prior to joining Amgen, Dr. Yarema held global roles for Novartis and McKinsey & Company, where she led project teams for companies across the U.S., Europe, and Asia.
Dr. Yarema graduated from University of California, Berkeley with a Ph.D. in Biochemical/Biomedical Engineering and Stanford University with a B.S. in Chemical Engineering with Distinction and B.A. in English with Distinction. In addition, she has served on the Board of Directors for the Celiac Disease Foundation, the U.S.-based patient-advocacy group.
Dr. Yarema is proficient in Advanced German and basic French and in her free time, enjoys cycling, music, food, wine, yoga and travel.
Location: Los Angeles Metropolitan Area, California, United States
Click here to view: Introduction by Kristin Yarema – Chief Commercial Officer – Atara Bio
For contact information, please email firstname.lastname@example.org